Go to the list of all blogs
Alicia's Avatar
published in Blogs
May 12, 2026
Why Is Under Armour, Inc. (UAA) Stock Down -19% Today?

Why Is Under Armour, Inc. (UAA) Stock Down -19% Today?

Key Takeaways

  • Shares of UAA are plunging approximately 19.00% on Tuesday, May 12, 2026, falling from a Monday, May 11 close of $6.07 to approximately $4.92 — a severe earnings-driven selloff triggered by Q4 fiscal 2026 results released before today's market open that delivered a headline EPS miss, a -7% North America revenue decline, a full-year fiscal 2026 net loss of $496 million, and a fiscal 2027 guidance framework that projects a further slight revenue decline — dashing any near-term recovery narrative and confirming that Under Armour's multi-year turnaround remains years away from delivering positive revenue momentum.

  • The primary catalyst is the Q4 fiscal 2026 earnings report: adjusted EPS of -$0.03 missed the -$0.02 consensus estimate by 50%, Q4 revenue of $1.2 billion declined 1% year-over-year, and the North America segment — UAA's core domestic market — posted a -7% revenue decline for Q4, extending the double-digit structural erosion pattern that has defined UAA's North American business across multiple consecutive fiscal years.

  • The fiscal 2027 guidance is the most alarming element driving today's extended selloff beyond the pre-market -12.88% gap: management's projection that fiscal 2027 full-year revenue will decline slightly from fiscal 2026's $5.0 billion — already down 4% from the prior year — means UAA is now guiding to a third consecutive year of top-line contraction, eliminating the revenue stabilization narrative that had provided any remaining bull-case foundation for the stock.

  • The scale of the fiscal 2026 GAAP loss — $496 million, or $1.16 per diluted share — reflects the accumulated impact of a $255 million restructuring program, gross margin compression of 240 basis points to 45.5%, and the operating leverage destruction that accompanies sustained revenue contraction in a fixed-cost intensive apparel and footwear manufacturing operation.

  • The broader athletic apparel sector context amplifies today's bearish market reaction: UAA is competing against Nike (NKE) and Adidas, both of which have larger marketing budgets, more established global distribution networks, and stronger brand equity in the key footwear category where UAA has been consistently losing market share — and fiscal 2027 guidance of continued revenue decline suggests the competitive gap is not closing at any pace that the market is willing to value.

  • Traders and investors will focus on whether the fiscal 2027 gross margin improvement of 220–270 basis points and adjusted operating income guidance of $140–$160 million represents a credible profitability recovery path even without top-line growth, or whether continued revenue contraction ultimately overwhelms any margin expansion benefit.

Opening Summary

Under Armour, Inc. (UAA) is a Baltimore, Maryland-based developer, marketer, and distributor of branded performance athletic apparel, footwear, and accessories — with a product portfolio spanning training, running, basketball, outdoor, and golf categories marketed under the Under Armour brand through wholesale distribution to major retailers, direct-to-consumer e-commerce and brand house stores, and international distributor and licensing partnerships across more than 100 countries, competing directly with Nike (NKE), Adidas, and Lululemon (LULU) for share of the global athletic apparel and footwear market. Shares are plunging approximately 19.00% on Tuesday, May 12, 2026, falling from a Monday, May 11 close of $6.07 to approximately $4.92, following Q4 fiscal 2026 earnings released before today's open at 6:55 a.m. ET that delivered adjusted EPS of -$0.03 (missing the -$0.02 consensus), Q4 revenue down 1%, North America revenue down 7%, a full-year fiscal 2026 net loss of $496 million, and a fiscal 2027 guidance framework projecting a further slight revenue decline — results that have extinguished any near-term turnaround optimism and triggered the largest single-session selloff in UAA in several months.

Q4 Fiscal 2026 Results: The Miss That Mattered

The fiscal Q4 2026 earnings miss — adjusted EPS of -$0.03 versus the -$0.02 consensus — is superficially small in absolute dollar terms, but its significance lies in the message it delivers about the trajectory of UAA's profitability improvement: even in a quarter where the company had the benefit of $255 million in cumulative restructuring actions, workforce rightsizing, and SKU rationalization, it still failed to meet a consensus EPS estimate of negative two cents. Q4 revenue of $1.2 billion — declining 1% year-over-year — represents the most recent data point in a sustained revenue contraction that has now delivered a 4% full-year fiscal 2026 decline to $5.0 billion. The gross margin deterioration of 240 basis points for the full fiscal year to 45.5% is particularly concerning for a business whose turnaround thesis depends on transitioning away from discount and promotional channels toward premium full-price selling — a channel mix improvement that is clearly not generating the margin expansion investors expected. Full-year fiscal 2026 net loss of $496 million ($1.16 per diluted share GAAP) represents the largest annual loss in UAA's recent history and reflects both the restructuring charge burden and the fundamental operating leverage destruction created by sustained revenue decline against a partially fixed cost base.

North America -7%: The Structural Core Decline

The most structurally alarming metric in today's Q4 fiscal 2026 report is the North America segment revenue declining 7% year-over-year — UAA's home market and historically its highest-margin, highest-volume region. North America represents the majority of UAA's total revenue and is the market where brand strength, retail shelf space, and direct-to-consumer momentum are most critical to the company's premium repositioning strategy. A -7% quarterly decline in this segment — following prior periods of similar magnitude declines — confirms that the strategic pullback from off-price and promotional e-commerce channels is not being offset by equivalent premium direct-to-consumer demand growth. While International revenue grew 10% in Q4 (a genuine positive), the International segment is structurally smaller than North America and cannot compensate for the domestic market deterioration at UAA's current revenue mix. The market is pricing the North American decline as a brand relevance problem — specifically, that UAA lacks the product innovation velocity, marketing investment scale, and retail relationship leverage necessary to arrest the domestic market share losses to Nike (NKE), Adidas, and emerging premium athletic brands.

Fiscal 2027 Guidance: Revenue Decline Continues

The single catalyst most responsible for the extension of UAA's decline from the pre-market -12.88% to approximately -19.00% in today's regular session is the fiscal 2027 guidance framework — which projects a further slight revenue decline from fiscal 2026's already-contracted $5.0 billion base, while projecting gross margin improvement of 220–270 basis points and adjusted operating income of $140–$160 million. The guidance structure reveals management's turnaround priority ordering: margin recovery before revenue recovery, restructuring completion before growth acceleration. Adjusted operating income guidance of $140–$160 million for fiscal 2027 — compared to essentially breakeven adjusted operating performance in fiscal 2026 — demonstrates that profitability improvements are achievable. However, a third consecutive year of revenue contraction in fiscal 2027 eliminates the revenue growth narrative entirely and positions UAA as a company in managed decline with improving margins rather than a brand experiencing a genuine commercial recovery.

Market Context and Trading Activity

Volume in UAA on May 12 is running at several multiples of the 30-day average of approximately 10 million shares as institutional holders process the guidance downgrade and accelerate position reduction. The stock's decline to approximately $4.92 — near the lower end of the 52-week range — removes the $5.50–$6.00 technical support zone that had previously contained the downside and establishes new multi-year closing lows that are likely to trigger systematic selling from strategies with minimum price quality criteria. The broader consumer discretionary sector and athletic apparel peer group are tracking the market positively Tuesday — with Nike (NKE) and Lululemon (LULU) holding relatively steady — confirming that today's 19.00% selloff is entirely UAA-specific and driven by the combination of Q4 miss, North America deterioration, fiscal 2026 GAAP loss magnitude, and fiscal 2027 continued revenue decline guidance.

Trending AI Robots

For traders navigating post-earnings structural decline selloffs and turnaround narrative collapses in consumer apparel companies like UAA today, Tickeron's Trending AI Robots page provides a curated view of the platform's strongest-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers, but only those demonstrating the highest real-time performance are featured in this section. Bots span a wide range of strategy types, holding timeframes, risk profiles, performance metrics, and traded symbol universes — from post-earnings gap-down continuation frameworks suited to consumer discretionary and athletic apparel names to systematic mean-reversion strategies designed to navigate brand turnaround cycles and retail channel restructuring timelines. Whether you are managing risk around a guidance-driven selloff in a major athletic apparel company or identifying structured setups across the broader consumer discretionary and sportswear sector, the Trending AI Robots page is a practical starting point for AI-assisted trading.

What Comes Next for UAA

The most critical near-term development for UAA is whether management's fiscal 2027 adjusted operating income guidance of $140–$160 million can be achieved without revenue growth — a proof-of-concept for the thesis that margin expansion from restructuring, channel mix improvement, and cost discipline can generate meaningful profitability even while top-line contraction continues. The Q1 fiscal 2027 earnings release — expected in early August 2026 — will provide the first quarterly confirmation of whether the gross margin improvement of 220–270 basis points projected for the full fiscal year is materializing in the actual product mix, pricing, and promotional cadence of the first quarter of the new fiscal year. Key risks include the possibility that North America revenue decline accelerates beyond the -7% Q4 pace as major retail partners reduce UAA shelf space allocations in response to brand momentum challenges; that the fiscal 2027 "slight revenue decline" guidance proves optimistic if consumer spending on athletic apparel weakens further in a tariff-driven inflationary environment; that International revenue growth (+10% in Q4) decelerates as European and Asian market competition intensifies; and that the sustained stock price decline below $5.00 creates headline pressure that affects UAA's relationships with retail channel partners, sponsored athletes, and prospective employees who assess the company's financial health in part through its market capitalization trajectory.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: UAA

Contributor

Alicia's AvatarAlicia|Beginner

UAA's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for UAA turned positive on October 01, 2026. Looking at past instances where UAA's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where UAA's RSI Oscillator exited the oversold zone, 29 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 59 cases where UAA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.

Following a +5.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where UAA advanced for three days, in 189 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

UAA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UAA as a result. In 65 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.

The 50-day moving average for UAA moved below the 200-day moving average on September 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UAA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for UAA entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.287) is normal, around the industry mean (5.929). P/E Ratio (20.955) is within average values for comparable stocks, (22.594). Projected Growth (PEG Ratio) (1.083) is also within normal values, averaging (0.686). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (0.434) is also within normal values, averaging (0.827).

The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. UAA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UAA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are VF Corp (NYSE:VFC), G-III Apparel Group Ltd (NASDAQ:GIII), Canada Goose Holdings (NYSE:GOOS), Lakeland Industries (NASDAQ:LAKE).

Industry description

Apparel/footwear might be slightly more ‘cyclical’ in the largely non-cyclical category of non-durables. While digital giants like Amazon have been rapidly expanding their presence, traditional clothing/footwear retailers have also been bulking up their online presence in recent years, to milk the burgeoning trend of online shopping among consumers across the globe. The apparel and footwear retail market was valued at around $ 360 billion in 2018, and this figure was expected to reach about $386 billion by 2020 (according to a Statista report). NIKE, Inc, V.F. Corporation and Under Armour, Inc. are some of the companies with the largest U.S. stock market caps in this segment.

Market Cap

The average market capitalization across the Apparel/Footwear Industry is 2.71B. The market cap for tickers in the group ranges from 1.66K to 25.98B. HMRZF holds the highest valuation in this group at 25.98B. The lowest valued company is SQBGQ at 1.66K.

High and low price notable news

The average weekly price growth across all stocks in the Apparel/Footwear Industry was 0%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 8%. JXG experienced the highest price growth at 18%, while NCI experienced the biggest fall at -61%.

Volume

The average weekly volume growth across all stocks in the Apparel/Footwear Industry was -24%. For the same stocks of the Industry, the average monthly volume growth was 12% and the average quarterly volume growth was -25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 54
Price Growth Rating: 64
SMR Rating: 71
Profit Risk Rating: 93
Seasonality Score: 37 (-100 ... +100)
View a ticker or compare two or three
UAA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a designer of branded performance products for men, women and youth

Industry ApparelFootwear

Industry
Apparel Or Footwear
Address
101 Performance Drive
Phone
+1 410 468-2512
Employees
14100
Web
https://www.underarmour.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
Why Is Under Armour, Inc. (UAA) Stock Down -19% Today?